InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
40%
T+90 mean return
-5.2%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Thornberry Nancy, Director. Director active across 3 companies, notably Denali Therapeutics Inc.. In total, 13 disclosures have been recorded. Activity tracked since 8 January 2022. The latest transaction was filed on 3 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations13 total
6,408 shares0Common StockSEC:0001797826-26-000002:0
398 shares0Common StockSEC:0000875320-25-000188:0
5,000 shares0Common StockSEC:0001490978-24-000056:0
5,967 shares0Common StockSEC:0001714899-24-000141:0
501 shares0Common StockSEC:0000875320-24-000131:0
1,136 shares0Common StockSEC:0000875320-23-000052:0
6,250 shares0Common StockSEC:0001490978-23-000081:0
4,216 shares0Common StockSEC:0001714899-23-000101:0
14,850 shares@ US$11.5274.1% of flowCommon StockSEC:0001490978-23-000050:0
4,950 shares@ US$11.5225.9% of flowCommon StockSEC:0001209191-22-045632:0
5,986 shares0Common StockSEC:0001714899-22-000091:0
627 shares0Common StockSEC:0001714899-22-000015:0
627 shares0Common StockSEC:0001714899-22-000015
13 of 13 declarations
About Thornberry Nancy
Nancy Thornberry is a Director at Denali Therapeutics Inc. She contributes to the strategy and governance of the company, bringing her experience in biotechnology. Her role is crucial for the development and implementation of strategic initiatives.
